| Dr Justin Imhof, DO | |
|
100 Medical Dr, Hannibal, MO 63401-6877 | |
| (573) 231-3871 | |
| (573) 231-3707 |
| Full Name | Dr Justin Imhof |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 100 Medical Dr, Hannibal, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225066509 | NPI | - | NPPES |
| 1225066509 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 2011001466 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blessing Hospital | Quincy, IL | Hospital |
| Hannibal Regional Hospital | Hannibal, MO | Hospital |
| Pike County Memorial Hospital | Louisiana, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blessing Hospital | 3072422534 | 345 |
News Archive
A brain-scan study in Germany has found evidence that women are particularly vulnerable to the harmful effects of excessive drinking.
For most people, trips to the doctor can be quite scary. For adolescents and young adults with autism, taking control of health care decisions is not only frightening, it also can be a barrier to independence.
BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.
› Verified 8 days ago
| Entity Name | Hannibal Clinic Operations, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427037225 PECOS PAC ID: 9931094182 Enrollment ID: O20040217001075 |
News Archive
A brain-scan study in Germany has found evidence that women are particularly vulnerable to the harmful effects of excessive drinking.
For most people, trips to the doctor can be quite scary. For adolescents and young adults with autism, taking control of health care decisions is not only frightening, it also can be a barrier to independence.
BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.
› Verified 8 days ago
| Entity Name | Hannibal Clinic Operations, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962481663 PECOS PAC ID: 9931094182 Enrollment ID: O20050310000149 |
News Archive
A brain-scan study in Germany has found evidence that women are particularly vulnerable to the harmful effects of excessive drinking.
For most people, trips to the doctor can be quite scary. For adolescents and young adults with autism, taking control of health care decisions is not only frightening, it also can be a barrier to independence.
BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.
› Verified 8 days ago
| Entity Name | Blessing Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114471737 PECOS PAC ID: 3072422534 Enrollment ID: O20171221000766 |
News Archive
A brain-scan study in Germany has found evidence that women are particularly vulnerable to the harmful effects of excessive drinking.
For most people, trips to the doctor can be quite scary. For adolescents and young adults with autism, taking control of health care decisions is not only frightening, it also can be a barrier to independence.
BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin Imhof, DO 100 Medical Dr, Po Box 311, Hannibal, MO 63401-6877 Ph: (573) 231-3871 | Dr Justin Imhof, DO 100 Medical Dr, Hannibal, MO 63401-6877 Ph: (573) 231-3871 |
News Archive
A brain-scan study in Germany has found evidence that women are particularly vulnerable to the harmful effects of excessive drinking.
For most people, trips to the doctor can be quite scary. For adolescents and young adults with autism, taking control of health care decisions is not only frightening, it also can be a barrier to independence.
BioSante Pharmaceuticals, Inc. today announced its financial results for the second quarter of 2011.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced preliminary data for the company's PH-10 Phase 2 clinical trial for Psoriasis as well as for its Phase 2 clinical trial for Atopic Dermatitis.
In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.
› Verified 8 days ago
Dr. Kevin B Imhof, D.O. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 6500 Hospital Dr, Hannibal, MO 63401 Phone: 573-629-3301 Fax: 573-629-3336 | |
Heather A Curtis, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6500 Hospital Dr, Hannibal, MO 63401 Phone: 573-629-3331 Fax: 573-629-3336 |